Literature DB >> 32509388

Aberrant USP11 expression regulates NF90 to promote proliferation and metastasis in hepatocellular carcinoma.

Changmao Zhang1, Chengrong Xie1, Xiaomin Wang1, Yayu Huang2, Shaoyang Gao3, Jing Lu1, Yuyan Lu1, Sheng Zhang3.   

Abstract

Growing evidence indicates that deubiquitinase ubiquitin-specific protease 11 (USP11) plays an important role in cellular function by regulating the stability of its substrates. USP11 is dysregulated in many types of cancer and involved in tumor development and progression. We previously showed that USP11 was upregulated in hepatocellular carcinoma (HCC) and promoted HCC cell invasion and metastasis potency. However, the mechanism underlying the role of USP11 in HCC cell metastasis and its function in cell proliferation remain unknown. Here, CCK-8, soft agar assays and nude mouse models showed that USP11 was essential for HCC cells survival and proliferation in vitro and in vivo. Results form mass spectrometry, co-immunoprecipitation, and ubiquitination assays demonstrated that USP11 interacted with nuclear factor 90 (NF90) and promoted its deubiquitination, thereby stabilizing it in HCC cells. Moreover, the effect of USP11 on promoting HCC cells proliferation and metastasis was dependent on NF90, and USP11 expression was positively correlated with NF90 expression in human HCC tissues, as demonstrated via immunohistochemistry. Collectively, the present findings indicated that USP11 binded to and deubiquitinated NF90, thereby stabilizing the protein expression level and promoting HCC cell proliferation and metastasis. NF90 was identified as an important downstream target of USP11. Dysregulated signaling of this novel USP11/NF90 axis might promote HCC proliferation and metastasis, and the axis could be a potential therapeutic target in HCC. AJCR
Copyright © 2020.

Entities:  

Keywords:  Hepatocellular carcinoma; metastasis; nuclear factor 90; proliferation; ubiquitin-specific protease 11

Year:  2020        PMID: 32509388

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  9 in total

1.  Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases.

Authors:  Ying Zhu; Jianguo Xu; Wei Hu; Fang Wang; Yan Zhou; Wei Gong; Wen Xu
Journal:  Aging (Albany NY)       Date:  2021-06-03       Impact factor: 5.682

2.  Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2.

Authors:  Lei Xu; Bin Zhang; Wenlan Li
Journal:  Mol Med Rep       Date:  2021-02-12       Impact factor: 2.952

3.  Circ_DOCK1 regulates USP11 through miR-132-3p to control colorectal cancer progression.

Authors:  Weitong Zhang; Zhenfen Wang; Guohao Cai; Ping Huang
Journal:  World J Surg Oncol       Date:  2021-03-08       Impact factor: 2.754

4.  Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma.

Authors:  Fang Wang; Peter Breslin S J; Wei Qiu
Journal:  Liver Res       Date:  2021-06-23

Review 5.  The role of ubiquitination and deubiquitination in tumor invasion and metastasis.

Authors:  Shuangze Han; Ruike Wang; Yangnan Zhang; Xiaoying Li; Yu Gan; Feng Gao; Pengfei Rong; Wei Wang; Wei Li
Journal:  Int J Biol Sci       Date:  2022-03-06       Impact factor: 6.580

6.  ERK-mediated Cytoplasmic Retention of USP11 Contributes to Breast Cancer Cell Proliferation by Stabilizing Cytoplasmic p21.

Authors:  Ling Li; Tanggang Deng; Lin Zhang; Yanpeng Wang; Yangyang Zhou; Yan Liu; Hui Li; Jing Dai; Yuan Yang; Neng Ling; Huimin Liu; Jing Liu; Lanqin Cao; Min Xu; Mao Ye
Journal:  Int J Biol Sci       Date:  2022-03-21       Impact factor: 6.580

Review 7.  Epigenetic modification regulates tumor progression and metastasis through EMT (Review).

Authors:  Tingshan Tan; Pengfei Shi; Muhammad Nadeem Abbas; Yi Wang; Jie Xu; Yu Chen; Hongjuan Cui
Journal:  Int J Oncol       Date:  2022-04-21       Impact factor: 5.884

8.  Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.

Authors:  Danping Sun; Mingxiang Zhang; Meng Wei; Zhaoyang Wang; Wen Qiao; Peng Liu; Xin Zhong; Yize Liang; Yuanyuan Chen; Yadi Huang; Wenbin Yu
Journal:  Aging (Albany NY)       Date:  2022-05-04       Impact factor: 5.955

Review 9.  Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management.

Authors:  Yihao Liao; Diansheng Zhou; Pu Wang; Mengyue Yang; Ning Jiang
Journal:  Cell Death Discov       Date:  2022-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.